Clinical Trial Update: BRIEF Bendamustine and Rituximab In Elderly Follicular [Phase 2]

View source ↗

Summary

A Phase 2 trial of Bendamustine and Rituximab in elderly patients with Follicular lymphoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Bendamustine (Bendamustine)
• Rituximab (rituximab)

Snippet

Sponsor: The Lymphoma Academic Research Organisation | Conditions: Follicular Lymphoma | Phase 2 | Status: TERMINATED